Immunoglobulins market size has been experiencing sturdy growth recent years and is projected to surge from $18.85 billion in 2024 to $20.53 billion in 2025, registering a compound annual growth rate (CAGR) of 8.9%. The surge in market size during the historic period can be attributed to the escalating prevalence of immunodeficiency disorders, burgeoning geriatric population, rising adoption of immunoglobulins in hospitals, advantageous government reimbursement plans, and an increasing prevalence of chronic and autoimmune diseases.
The market size is predicted to witness rapid growth, reaching $31.59 billion in 2029 at a compound annual growth rate (CAGR) of 11.4%. Crucial factors driving the market forecast include growing investment for the development of advanced technologies, increasing awareness about immunodeficiency therapies, rising preference among physicians for immunodeficiency therapies, burgeoning number of emerging markets, and the expansion of applications in the sports and fitness sector.
Get Your Free Sample of The Global Immunoglobulins Market Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=5284&type=smp
What Are The Key Drivers Fueling The Immunoglobulins Market Growth?
A factor central to driving the growth of the immunoglobulins market is the increasing geriatric population. This section of the population is prone to infectious and auto-immune diseases. Immunoglobulin tests gauge the body’s capacity to generate antibodies that protect it from bacteria, viruses, and allergies. As per the World Health Organization (WHO) report of October 2022, by the year 2030, one in six people across the world is predicted to be 60 or older. By 2050, there will be 2.1 billion people worldwide aged 60 years or older, thus potentially bolstering the immunoglobulins market demand.
What Are The Major Segments In The Global Immunoglobulins Market?
The immunoglobulins market covered in this report can be segmented into:
1) By Product: IGG, IGA, IGM, IGE, IGD
2) By Mode Of Delivery: Intravenous Mode Of Delivery, Subcutaneous Mode Of Delivery
3) By Application: Hypogammaglobulinemia, Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Immunodeficiency Disease, Myasthenia Gravis, Idiopathic Thrombocytopenic Purpura (ITP), Other Applications
Order Your Exclusive Report Here for Swift Delivery:
https://www.thebusinessresearchcompany.com/report/immunoglobulins-global-market-report
Who Are The Major Players Operating In The Immunoglobulins Market?
Prominent companies making waves in the immunoglobulins sector include Baxter International Inc., CSL Behring LLC, Grifols S. A., Octapharma AG, China Biologic Products Holdings Inc., Kedrion SpA, LFB SA, Biotest AG, Sanquin Blood Supply Foundation, ADMA Biologics Inc., Option Care Health Inc., Shanghai RAAS Blood Products Co. Ltd., Antibody Solutions, Bio Products Laboratory Ltd., Immunovant Inc., Kamada Ltd., Emergent BioSolutions Inc., Fresenius Kabi AG, GlaxoSmithKline plc, Pfizer Inc., Roche Holding AG, Samsung Bioepis Co. Ltd., Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Zydus Cadila Healthcare Limited.
What Are The Emerging Trends In The Immunoglobulins Market?
Major companies in the immunoglobulins sector are delving into the development of groundbreaking products such as intravenous immunoglobulins to cater to larger customer bases, boost sales, and increase revenue. One such instance is GC Biopharma, which launched ALYGLO™ (Immune Globulin Intravenous, Human-stwk) 10% Liquid in September 2024 in the U.S. market. The product targets the treatment of primary humoral immunodeficiency (PI) in adults aged 17 years and older.
Which Region Dominates The Immunoglobulins Market And Which Is Projected To Grow The Fastest?
North America held the largest share in the immunoglobulins market in 2024, while the Asia-Pacific region is anticipated to be the fastest-growing during the forecast period. The regions scrutinized in the immunoglobulins market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
What Does The Immunoglobulins Market Report Offer?
Immunoglobulins refer to glycoproteins, also known as antibodies, that are produced by plasma cells (white blood cells). They play a pivotal role in the immune response by selectively recognizing and binding to specific antigens, such as viruses or bacteria, helping to eliminate them. The Immunoglobulins Market research report from The Business Research Company presents global market size, growth rate, regional shares, competitor analysis, comprehensive segments, trends, and opportunities.
Invest In The Exclusive Report Now To Unlock Exceptional Market Insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=5284
About The Business Research Company
Boasting over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has established a reputation for delivering comprehensive, data-rich research and insights. With 1,500,000 datasets, you can benefit from an in-depth secondary research and unique insights presented by industry leaders to stay ahead with your decisions.
Read Related Topics:
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
